A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/225 (2006.01)
Patent
CA 2589654
A method and composition for blood lipid therapy by administering to the subject an effective amount of a dyslipidemic agent and omega-3 fatty acids. The method utilizes a single administration or a unit dosage of a combination of dyslipidemic agent and omega-3 fatty acids for the treatment of patients with hypertriglyceridemia, hypercholesterolemia, mixed dyslipidemia, coronary heart disease (CHD), vascular disease, artherosclerotic disease and related conditions, and the prevention or reduction of cardiovascular and vascular events.
La présente invention concerne un procédé et une composition de thérapie des lipides sanguins, par administration à la personne d'une quantité efficace d'un agent dyslipidémique et d'acides gras oméga-3. Le procédé fait intervenir une administration unique ou un dosage unitaire d'une combinaison d'agent dyslipidémique et d'acides gras oméga-3 pour le traitement de patients atteints d'hypertriglycéridémie, d'hypercholestérolémie, de dyslipidémie mixte, de maladie cardiaque coronarienne (coronary heart disease / CHD), de troubles vasculaires, de troubles arthérosclérotiques et états pathologiques associés, et pour prévenir et limiter l'apparition de troubles cardio-vasculaires et vasculaires.
Bobotas George
Rongen Roelof M. L.
Reliant Pharmaceuticals Inc.
Smart & Biggar
LandOfFree
Omega-3 fatty acids and dyslipidemic agent for lipid therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Omega-3 fatty acids and dyslipidemic agent for lipid therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Omega-3 fatty acids and dyslipidemic agent for lipid therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1928930